AuntMinnie
OCTOBER 30, 2024
Telix Pharmaceuticals has entered an agreement to add Subtle Medical’s AI software for enhancing prostate-specific membrane antigen (PSMA) PET prostate cancer scans to its product portfolio. The algorithm allows for faster PET scanning, up to 75% faster without compromising image quality, according to the company.
AuntMinnie
MARCH 7, 2025
The group analyzed flortaucipir (Tauvid, Avid Pharmaceuticals) PET scans acquired over a 3.5-year Moreover, currently, approximately a quarter of postmenopausal women who are 70 years and older have a history of HT use and have now entered a critical age of risk for Alzheimers disease, the authors added.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Radiology Business
AUGUST 26, 2024
The Swiss pharmaceutical firm operates Europe’s second largest network of cyclotrons, used to manufacture radioactive compounds needed for PET scans.
AuntMinnie
JANUARY 27, 2025
Quibim has closed a $50 million series A financing round to support strategic collaborations with hospitals and pharmaceutical companies in the U.S. The company has been developing human digital twin technology at the organ and lesion level, as well as foundational AI models designed to extract actionable insights from MRI, CT, and PET scans.
Imaging Technology
JUNE 15, 2023
For pharmaceutical companies and researchers, using this tracer to better understand the mechanism of action - i.e. the effect of immunotherapies on a patient’s immune response to their cancer - could, potentially, enable them to better select patients to participate in clinical trials and bring new immunotherapies to market. Fruhwirth, G.
Imaging Technology
OCTOBER 20, 2023
announced a research collaboration agreement with the Alzheimer’s Disease Neuroimaging Initiative 4, ADNI4, on the use of Meilleur’s [F-18]NAV-4694, an investigational imaging agent, in Positron Emission Tomography (PET) scans to assess the status amyloid plaque in the brain.
Expert insights. Personalized for you.
147 
Let's personalize your content